2 results
Search Results
Now showing 1 - 2 of 2
Article Citation - Scopus: 1Anxiety and Depression After Cesarean: Non-Pharmacological Evidence Based Practices;(Dokuz Eylul University, 2022) Terzioğlu,F.; Gençbaş,D.; Boztepe,H.; Doğu,N.; Akdeniz,C.; Yüceer,B.The purpose of this review is to examine the non-pharmacological evidence-based practices of anxiety and depression after a cesarean section delivery. Postpartum anxiety and depression have increased in the last decade, the rates of postpartum depression are around 13% worldwide. In the postpartum period, women may experience anxiety and depression due to the operation they have undergone; such as being in an unfamiliar environment, facing new technological equipment and encounters with the medical teams, the post-operative pain, the new roles women undertake as mothers. One of the factors that increase anxiety and depression in the postpartum period is the type of delivery. In Turkey, the rate of cesarean delivery is comparatively high, which is approximately 52%. Anxiety and depression after cesarean section develop due to fear and concern such as the complications that may occur during and after the mother's anesthesia, the possibility delaying breastfeeding her baby, and experiencing pain. Non-pharmacological evidence-based applications such as reiki, acupressure, hand and foot massage, yoga, reflexology, aromatherapy, skin to skin care, nursing care protocols were found to be effective in studies conducted to reduce anxiety and depression after cesarean-section. Nurses who have critical roles and responsibilities in pre-and post-cesarean care practices are recommended to include these evidence-based non-pharmacological practices in routine care practices. © 2022, Dokuz Eylul University. All rights reserved.Article Challenges Faced by Pediatric Patients With Multiple Sclerosis During Disease Progression and Treatment: A Multicenter Cross-Sectional Study in Turkiye(Asean Neurological Assoc, 2025) Yuksel, Didem; Yardimci, FigenBackground & Objective: Multiple sclerosis is a chronic and progressive disease characterized by inflammation, demyelination and degeneration of the central nervous system. This study aimed to describe the sociodemographic and clinical characteristics of children with multiple sclerosis. Methods: The cross-sectional study was collected data from 120 children who met the research criteria and were under follow-up at 7 hospitals in T & uuml;rkiye between August 2021 and February 2022. Ethical approval was obtained from the Medical Research Ethics Committee of Ege University. The researchers developed the "The Sociodemographic Form "used in the study by based on a comprehensive literature review and previous research experiences. The form was used according to expert opinion. Results: The study included 120 eligible patients, of whom 71.2% were girls. The mean age (+/- SD) at disease onset was 13.6 +/- 2.2 years, while the mean age at the time of the study was 15.7 +/- 1.5 years. Most of the participants were high school students (84.2%), and 53.3% resided in metropolitan areas. All participants were receiving disease-modifying therapy. The study found that 67.5% of the children had school absenteeism due to the disease. Furthermore, 75% of the children experienced supratentorial symptoms, with 50% presented with optic symptoms, and 37.5% exhibiting brainstem symptoms prior to diagnosis. Drug-related side effects were reported in 58.3% of children. Additionally,99.2% of the children received information about the disease. Furthermore, 75% of the children experienced challenges during the disease and treatment process. Among these children who encountered difficulties, 52.5% reported psychological problems, 42.5% experienced side effects due to medication, 42.5% had difficulty accessing accurate and sufficient information about disease and treatment management, 32.5% encountered social and school-related issues, and 5.8% had concerns related to the clinical environment. Conclusion: Childhood multiple sclerosis is more prevalent among girls, particularly in the relapsing-remitting form. The most commonly used treatments for pediatric multiple sclerosis include interferon beta-1a and glatiramer acetate. The findings of this study indicate that a significant proportion of participating children encountered challenges during the disease and treatment process, with more than half experiencing drug-related side effects. These challenges underscore the potential negative impact on treatment adherence in this population.
